GRANULES stock news on Anadi Algo News

Sunday, March 15, 2026
DISCLAIMER: AI-generated signals are for informational purposes only. All trading and investment decisions are solely the user's responsibility.|Past performance does not guarantee future results. Trade at your own risk.|Anadi Algo is not a SEBI-registered advisor. Consult a qualified financial advisor before acting on any recommendation.|DISCLAIMER: AI-generated signals are for informational purposes only. All trading and investment decisions are solely the user's responsibility.|Past performance does not guarantee future results. Trade at your own risk.|Anadi Algo is not a SEBI-registered advisor. Consult a qualified financial advisor before acting on any recommendation.|
AnadiAlgoNews
सट्टा नहीं, सिस्टम
Stock Landing|2 matching stories

GRANULES Stock News, Sentiment & Trading Insights

Latest AI-analyzed news for GRANULES, including sentiment, related articles, and market-moving coverage.

Top Story|et_companiesabout 11 hours ago

Kathua to become India’s antibiotic powerhouse with Rs 600 crore pharma facility

The Indian pharma sector is actively working to reduce its reliance on imported APIs, especially from China. This investment aligns with the government's 'Make in India' push and Production Linked Incentive (PLI) schemes for pharmaceuticals.

buy
Bullish+6590%
PharmaceuticalsChemicals
+65

Impact Score

Affected Stocks

AUROPHARMAAurobindo Pharma Ltd.
Positive
DIVISLABDivi's Laboratories Ltd.
Positive
GRANULESGranules India Ltd.
Positive
LUPINLupin Ltd.
Positive
Look for opportunities in API-focused pharma companies, as this development signals continued government support and potential for domestic growth, with a bias towards long positions.
et_economy5 days ago

India's exports of active pharma ingredients at Rs 41,500 cr surpassed imports in FY25

The pharmaceutical sector is strategically important for India. Reducing import dependence for APIs enhances supply chain security and boosts domestic manufacturing capabilities.

buy
Bullish+66.595%
5 factsGRANULES
Long-term bullish on Indian API manufacturers, especially those participating in the PLI scheme.|Quick check: GRANULES bullish bias (+4.0% 1d), SUNPHARMA bullish bias (overbought).